Drug before surgery aims to slash need for follow-up radiation in prostate cancer
NCT ID NCT03412396
Summary
This study is testing whether taking a hormone therapy drug called apalutamide for six months before prostate removal surgery can help patients avoid needing radiation therapy afterward. It involves 45 men with intermediate-risk prostate cancer. The goal is to see if this pre-surgery treatment reduces certain high-risk features in the tumor that typically lead doctors to recommend post-surgery radiation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.